既往筛查阴性者粪便血红蛋白水平与结直肠肿瘤检出:剂量-反应荟萃分析
该系统综述与荟萃分析纳入13项研究、共4,493,672人,评估平均风险人群既往筛查轮次粪便血红蛋白(f-Hb)水平与结直肠肿瘤检出的剂量-反应关系。汇总分析显示,f-Hb为5、10、20、40 μg/g者结直肠肿瘤风险分别约为0 μg/g者的3、5、8、13倍,异质性I²=97.5%(P<.001),敏感性分析结果一致。
要点
- 既往筛查f-Hb 5、10、20、40 μg/g者结直肠肿瘤风险分别约为0 μg/g者的3、5、8、13倍。
- 异质性I²=97.5%(P<.001),敏感性分析证实结果一致性。
- 亚组分析提示既往阴性检测的f-Hb对后续筛查中进展期肿瘤尤其有预测价值。
核心结论
- 既往阴性检测中f-Hb浓度越高,结直肠肿瘤检出风险越高,支持基于该浓度制定风险分层筛查策略。
研究设计与样本
- 系统综述与荟萃分析,检索报告既往筛查轮次f-Hb与平均风险人群结直肠肿瘤检出关联的研究。
- 纳入13项研究,共4,493,672人。
- 采用两阶段法,以log-log回归模型评估跨研究的剂量-反应关系,效应量用随机效应模型合并。
- 通过逐一排除单项研究进行敏感性分析评估异质性,并按结局定义和检测方法进行亚组分析。
主要发现
- 全部研究均显示既往筛查f-Hb与结直肠肿瘤检出呈正相关。
- 与f-Hb 0 μg/g者相比,f-Hb 5、10、20、40 μg/g者结直肠肿瘤风险分别约为3倍、5倍、8倍、13倍。
- 观察到显著异质性(I²=97.5%,P<.001),敏感性分析证实结果一致性。
- 亚组分析提示既往阴性检测的f-Hb浓度对后续筛查中进展期肿瘤尤其有预测价值。
关键数值与推荐
- f-Hb 5 μg/g者结直肠肿瘤风险约为0 μg/g者的3倍。
- f-Hb 10 μg/g者结直肠肿瘤风险约为0 μg/g者的5倍。
- f-Hb 20 μg/g者结直肠肿瘤风险约为0 μg/g者的8倍。
- f-Hb 40 μg/g者结直肠肿瘤风险约为0 μg/g者的13倍。
- 异质性I²=97.5%,P<.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 观察到显著异质性(I²=97.5%,P<.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Prior studies have shown that individuals with fecal hemoglobin (f-Hb) concentrations just below the positivity cutoff have an increased colorectal cancer risk compared with those with no or low f-Hb. Understanding the dose-response association between f-Hb in a prior screening round and the detection of colorectal neoplasia is crucial for tailoring risk-based screening recommendations. METHODS: We searched the literature to identify studies reporting the association between f-Hb in prior screening round and colorectal neoplasia detection in an average-risk population. Analysis involved a 2-stage approach using log-log regression models to assess dose-response relationships across studies, with effect sizes pooled using a random effects model. Heterogeneity was assessed by excluding individual studies in sensitivity analyses. Subgroup analyses examined variations in effects by outcome definitions and detection methods. RESULTS: This systematic review and meta-analysis included 13 studies with 4,493,672 individuals. All studies demonstrated a positive association between f-Hb in prior screenings and colorectal neoplasia detection. Pooled analysis revealed that individuals with f-Hb concentrations of 5, 10, 20, and 40 μg/g had a 3-, 5-, 8-, and 13-fold higher risk of colorectal neoplasia, respectively, compared with individuals with 0 μg/g. Although significant heterogeneity (I2 = 97.5%, P < .001) was observed, sensitivity analyses confirmed the consistency of findings. Subgroup analyses indicated that f-Hb concentrations from previous negative tests were especially predictive of advanced neoplasia in subsequent screenings. CONCLUSIONS: Our findings suggest that the risk of detecting colorectal neoplasia increases with prior f-Hb concentrations in negative tests, supporting the development of risk-stratified screening strategies based on these concentrations.
引用
- van den Berg DMN, van den Puttelaar R, de Jonge L, et al. Fecal Hemoglobin Levels in Prior Negative Screening and Detection of Colorectal Neoplasia: A Dose-Response Meta-Analysis. Gastroenterology. 2024. PMID: 39612955. doi:10.1053/j.gastro.2024.10.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。